SUN bioscience Company
SUN bioscience is enabling personalized medicine through patient-specific organoids cultured on SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development.
The SUN technology is solving the problems that organoid culture today cannot be scaled and automated. This will introduce a new area of drug discovery where we can understand drug performance outside of an animal or a human being.
Investors
.png)
.png)
Total Funding:
755719
Founded Date:
2015-01-01
Industry:
Quantum Biology
Last Funding Date:
2021-05-11
Funding Status:
private
Headquarters:
Lausanne,Vaud,Switzerland,Europe
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
755719
Last Funding Total Usd:
553124
Last Funding Total Currency:
CHF
Last Funding Total Value:
500000
Founders:
Nathalie Brandenberg,Sylke Hoehnel
Phone Number:
41216931615